Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review

Reduction of hazard risk of cerebral ischemic event (stroke, transient ischemic attack (TIA)) represents the hard point to be achieved from primary or secondary preventive strategy in the best clinical practice. However, results from clinical trials, recommendations, guidelines, systematic review, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Signorelli, Salvatore Santo, Platania, Ingrid, Tomasello, Salvatore Davide, Mangiafico, Marco, Barcellona, Giuliana, Di Raimondo, Domenico, Gaudio, Agostino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460138/
https://www.ncbi.nlm.nih.gov/pubmed/32806734
http://dx.doi.org/10.3390/ijerph17165840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460138/
https://www.ncbi.nlm.nih.gov/pubmed/32806734
http://dx.doi.org/10.3390/ijerph17165840

Ejemplares similares